Article Details

Vistagen Therapeutics (NASDAQ:VTGN) Rating Reiterated by Chardan Capital

Retrieved on: 2019-12-04 12:18:45

Tags for this article:

Click the tags to see associated articles and topics

Vistagen Therapeutics (NASDAQ:VTGN) Rating Reiterated by Chardan Capital. View article details on hiswai:

Excerpt

<div>Virtu Financial LLC purchased a new stake in Vistagen Therapeutics in the ... Three analysts have issued estimates for <b>Mogo Finance Technology's</b> ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up